8 Knots Management LLC Makes New $28.52 Million Investment in Cardinal Health, Inc. $CAH

8 Knots Management LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAHFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 138,795 shares of the company’s stock, valued at approximately $28,522,000. Cardinal Health accounts for 3.3% of 8 Knots Management LLC’s investment portfolio, making the stock its 9th biggest position.

A number of other hedge funds have also modified their holdings of CAH. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $25,000. Bank of Jackson Hole Trust bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $27,000. Jones Financial Companies Lllp boosted its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the period. Palladiem LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $28,000. Finally, JPL Wealth Management LLC bought a new position in shares of Cardinal Health in the third quarter worth approximately $31,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $223.76 on Friday. The firm has a fifty day moving average price of $203.21 and a 200 day moving average price of $208.85. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The firm has a market cap of $52.41 billion, a price-to-earnings ratio of 34.21, a P/E/G ratio of 1.22 and a beta of 0.52.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter last year, the business earned $2.35 earnings per share. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.19%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CAH shares. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a research report on Friday, May 1st. Evercore dropped their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. William Blair initiated coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Morgan Stanley upped their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Finally, TD Cowen upped their target price on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.93.

Check Out Our Latest Research Report on CAH

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.